Case study 1: Evidence-based evolution: when AI becomes the responsible choice for NHS dermatology

NHS dermatology is in crisis. Skin cancer referrals are rising exponentially, and workforce shortages are leaving patients waiting too long for critical diagnoses. Despite sustained efforts from dermatology teams, ongoing delays are impacting survival rates. In this session, Rachael will present how AI is the only option to handle demand and reserve dermatology capacity to see and treat patients in greatest need. Already transforming pathways across the NHS, Skin Analytics' Class III AI medical device, DERM, has proven to autonomously and safely discharge patients with benign lesions, releasing dermatology capacity, reducing wait times and ultimately, improving patient outcomes.